Fengcai Zhu is currently the deputy director of Jiangsu Provincial Center for Disease Control and Prevention, chief physician, doctoral supervisor, the first-level training target of Jiangsu Province’s “333 Project”, and selected into the “National Hundred Thousand Talents Project”. He has successively won the honorary titles of “Young and Middle-aged Experts with Outstanding Contributions” and “National Outstanding Science and Technology Workers” from the Ministry of Personnel, the National Health and Family Planning Commission, and Jiangsu Province. He is mainly engaged in infectious disease prevention and control research. As the main researcher, he is responsible for more than 100 vaccine clinical evaluations, including the only five innovative vaccines in my country in recent years, and has contributed to my country’s transition from a major vaccine user to a major R&D power; he led the team to confirm the world’s first human infection with H7N4 avian influenza. He screened and prepared a variety of fully human monoclonal antibodies against a variety of viruses, inventing more than 10 related patents. He has presided over five provincial and ministerial-level projects, including major scientific and technological projects, “863” projects, and the National Natural Science Foundation; won nine provincial and ministerial-level scientific and technological awards; published more than 400 papers, more than 100 of which were included in SCI.